Biotech Values

[DewDiligence]

ZSAR IPOs 5.2M* shares @$11.00:

http://finance.yahoo.com/news/zosano-pharma-announces-pricing-initial-132451802.html

Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications. Zosano's microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections… It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies.

*Assuming exercise of underwriter’s option.